•
Jun 30, 2017

CRISPR Therapeutics Q2 2017 Earnings Report

Total Revenue
$3.58M
Previous year: $795K
+350.6%
EPS
-$0.56
Previous year: -$0.946
-40.8%
Gross Profit
-$13.5M
Previous year: -$7.81M
+73.4%
Cash and Equivalents
$272M
Previous year: $247M
+10.3%
Free Cash Flow
-$40.7M
Total Assets
$305M

CRISPR Therapeutics

CRISPR Therapeutics